Cardiovascular disease and risk in COPD: a state of the art review.
Ricardo PolmanJohn R HurstOmer Faruk UysalSwapna MandalDominik LinzSami SimonsPublished in: Expert review of cardiovascular therapy (2024)
The prospective identification of co-morbid COPD in CVD patients and of CVD and CV risk in people with COPD is crucial for optimizing clinical outcomes. This includes the identification of novel treatment targets and the design of clinical trials specifically designed to reduce the cardiovascular burden and mortality associated with COPD. Databases searched: Pubmed, 2006-2023.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- cardiovascular disease
- clinical trial
- newly diagnosed
- cardiovascular events
- type diabetes
- cystic fibrosis
- bariatric surgery
- air pollution
- patient reported outcomes
- metabolic syndrome
- bioinformatics analysis
- machine learning
- weight loss
- patient reported
- smoking cessation